Skip to main content

Table 1 Association between AMIGO2 expression and clinicopathological factors. The chi-square test and Fisher's exact test were used for the statistical analyses

From: The impact of AMIGO2 on prognosis and hepatic metastasis in gastric cancer patients

parameter

 

AMIGO2 expression

P value

 

negative

positive

 
 

n = 99

n = 29

 

Age(years)

 < 70

44

14

0.715

 ≥ 70

55

15

 

Sex

male

71

26

0.047a

female

28

3

 

BMI

 < 25

82

26

0.283

 ≥ 25

17

3

 

Neoadjuvant chemotherapy

yes

9

2

0.526

no

90

27

 

Adjubant chemotherapy

yes

30

11

0.439

no

69

18

 

Stage (UICC 7th)

I

48

14

0.086

II

28

3

 

III

20

10

 

IV

3

2

 

Histlogical type

poor/sig

54

10

0.057

well/mod/other

45

19

 

Vascular invasion

negative

42

5

0.013 a

positive

57

24

 

Lymphatic invasion

negative

34

7

0.300

positive

65

22

 

pT

I/II

56

16

0.894

III/IV

43

13

 

pN

0

58

15

0.512

1

41

14

 

CEA (ng/mL)

 < 5

78

20

0.272

 ≥ 5

21

9

 

CA19-9 (U/mL)

 < 35

87

26

0.545

 ≥ 35

12

3

 

Liver metastasis

presence

7

8

0.006 a

absence

92

21

 

Peritoneal dissemination

presence

12

8

0.047 a

absence

87

21

 
  1. BMI body mass index, sig/poor/mod/well signet-ring cell/poorly/moderately/well differentiated, pT/N pathological T/N stage, CEA carcinoembryonic antigen, CA19-9 carbohydrate antigen19-9, astatistically significant, the chi-square test and Fisher's exact test were used for the statistical analyses
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us